DK3406258T3 - Medikament til anvendelse til behandling af urinsyregigt - Google Patents

Medikament til anvendelse til behandling af urinsyregigt Download PDF

Info

Publication number
DK3406258T3
DK3406258T3 DK17743673.0T DK17743673T DK3406258T3 DK 3406258 T3 DK3406258 T3 DK 3406258T3 DK 17743673 T DK17743673 T DK 17743673T DK 3406258 T3 DK3406258 T3 DK 3406258T3
Authority
DK
Denmark
Prior art keywords
medicine
treatment
urinary acid
urinary
acid
Prior art date
Application number
DK17743673.0T
Other languages
English (en)
Inventor
Qian Cheng
Long Cheng
Baozhen Xu
Original Assignee
Shandong Zhonghai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong Zhonghai Pharmaceutical Co Ltd filed Critical Shandong Zhonghai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK3406258T3 publication Critical patent/DK3406258T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7012—Compounds having a free or esterified carboxyl group attached, directly or through a carbon chain, to a carbon atom of the saccharide radical, e.g. glucuronic acid, neuraminic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/19—Acanthaceae (Acanthus family)
    • A61K36/195—Strobilanthes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • A61K36/315—Isatis, e.g. Dyer's woad
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK17743673.0T 2016-01-29 2017-01-20 Medikament til anvendelse til behandling af urinsyregigt DK3406258T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201610063691.9A CN105709207A (zh) 2016-01-29 2016-01-29 一种用于治疗痛风的药物
PCT/CN2017/071864 WO2017129058A1 (zh) 2016-01-29 2017-01-20 一种用于治疗痛风的药物

Publications (1)

Publication Number Publication Date
DK3406258T3 true DK3406258T3 (da) 2022-05-30

Family

ID=56154434

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17743673.0T DK3406258T3 (da) 2016-01-29 2017-01-20 Medikament til anvendelse til behandling af urinsyregigt

Country Status (15)

Country Link
US (1) US10653746B2 (da)
EP (1) EP3406258B1 (da)
CN (1) CN105709207A (da)
CY (1) CY1125271T1 (da)
DK (1) DK3406258T3 (da)
ES (1) ES2914280T3 (da)
HR (1) HRP20220667T1 (da)
HU (1) HUE058645T2 (da)
LT (1) LT3406258T (da)
PL (1) PL3406258T3 (da)
PT (1) PT3406258T (da)
RS (1) RS63233B1 (da)
SI (1) SI3406258T1 (da)
SM (1) SMT202200221T1 (da)
WO (1) WO2017129058A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105709207A (zh) * 2016-01-29 2016-06-29 徐宝贞 一种用于治疗痛风的药物
CN105641681A (zh) * 2016-01-29 2016-06-08 徐宝贞 一种用于治疗糖尿病的药物
CN105582522A (zh) * 2016-01-29 2016-05-18 山东中海制药有限公司 一种用于治疗肺结核的药物
CN112138138B (zh) * 2020-11-19 2023-05-23 乐康珍泰（天津）生物技术有限公司 一种用于治疗痛风的药物组合物及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK111489D0 (da) * 1989-03-08 1989-03-08 Novo Nordisk As Peptider
JP2003335698A (ja) * 2002-05-20 2003-11-25 Maruha Corp 高尿酸血症治療又は予防用組成物
CN101002873B (zh) * 2007-01-29 2011-06-01 张光辉 一种治疗复发性痛风的药物及其制备方法
JP5414995B2 (ja) * 2007-03-27 2014-02-12 国立大学法人鳥取大学 フコイダンを有効成分とする酸性尿改善飲食物および経口投与用医薬組成物
CN101760492B (zh) * 2008-12-24 2013-08-14 徐宝贞 提取藻糖蛋白的方法
JP2010235517A (ja) * 2009-03-31 2010-10-21 Kurorera Kogyo Kk 生活習慣病予防材及びそれを用いた飲食品
CN101703710A (zh) * 2009-10-22 2010-05-12 吴云霞 治疗痛风病的中药制剂
CN102077933B (zh) * 2010-09-20 2013-04-24 王强 一种高尿酸患者专用的海洋特膳食品
US9271952B2 (en) * 2011-10-11 2016-03-01 Complexa, Inc. Compositions and methods for treating nephropathy
CN102920743B (zh) * 2012-11-15 2015-11-18 浙江现代中药与天然药物研究院有限公司 螺旋藻在制备抗高尿酸血症和抗痛风药物或保健食品中的应用
CA2888647A1 (en) 2012-11-20 2014-05-30 Revive Therapeutics Inc. The use of bucillamine in the treatment of gout
CN103893226A (zh) * 2012-12-28 2014-07-02 中国科学院上海生命科学研究院湖州营养与健康产业创新中心 肉豆蔻提取物的应用
CN103585561B (zh) 2013-11-25 2015-07-29 哈药集团中药二厂 一种治疗痛风的中药组合物
US9527879B2 (en) 2014-05-23 2016-12-27 Korea Institute Of Science And Technology Aster glehni extracts, fractions or compounds isolated therefrom for the treatment or prevention of hyperuricemia or gout
CN105709207A (zh) * 2016-01-29 2016-06-29 徐宝贞 一种用于治疗痛风的药物

Also Published As

Publication number Publication date
CY1125271T1 (el) 2025-03-28
HUE058645T2 (hu) 2022-09-28
WO2017129058A1 (zh) 2017-08-03
EP3406258A1 (en) 2018-11-28
EP3406258A4 (en) 2019-03-13
HRP20220667T1 (hr) 2022-08-05
US20190038706A1 (en) 2019-02-07
EP3406258B1 (en) 2022-03-02
US10653746B2 (en) 2020-05-19
LT3406258T (lt) 2022-06-10
SMT202200221T1 (it) 2022-07-21
RS63233B1 (sr) 2022-06-30
PT3406258T (pt) 2022-05-30
SI3406258T1 (sl) 2022-07-29
CN105709207A (zh) 2016-06-29
ES2914280T3 (es) 2022-06-08
PL3406258T3 (pl) 2022-06-13

Similar Documents

Publication Publication Date Title
LT3334422T (lt) Kanabidiolio rūgšties panaudojimas epilepsijos gydymui
DK3728271T3 (da) Makrocykliske forbindelser til behandling af sygdomme
DK3326641T3 (da) Rna-holdig sammensætning til behandling af tumorsygdomme
DK3240612T3 (da) Fremgangsmåder til behandling af nethindesygdomme
DK3347030T3 (da) Brug af pasteuriseret akkermansia til behandling af stofskiftesygdomme
DK3504187T3 (da) Anvendelse af pridopidin til behandling af funktionel tilbagegang
DK3521282T3 (da) Quinazolinderivater anvendt til behandling af hiv
DK3212233T3 (da) Kombinationsterapi til behandling af sygdom
DK3119397T3 (da) Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
DK3277815T3 (da) Oligonukleotidforbindelser til behandling af præeklampsi og andre angiogene lidelser
EP3263132C0 (en) COMPOSITION FOR THE TREATMENT OF DISEASES ASSOCIATED WITH IL-6
DK3125875T3 (da) Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande
DK3169328T3 (da) Quinolinderivater til behandling af inflammationssygdomme
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
DK3865484T3 (da) Pde9-hæmmer med imidazopyrazinon-rygrad til behandling af perifere sygdomme
DK3524255T3 (da) Sammensætning til behandling af acne
HUE059303T2 (hu) Acetilkolin-észteráz-gátlók bõrbetegségek kezelésére
DK3236960T3 (da) Fluralaner til anvendelse i behandling af demodicose
DK3210973T3 (da) Heteroarylforbindelser til behandling af oftalmiske sygdomme
DK3430143T3 (da) Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme
DK3400072T3 (da) Formuleringer til behandling af blærecancer
DK3578562T3 (da) L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme
DK3452100T3 (da) FARMACEUTISKE BÆRERE INDEHOLDENDE miRNAer TIL ANVENDELSE I BEHANDLINGEN AF FIBROTISKE SYGDOMME FORÅRSAGET AF HYPERGLYKÆMI